The University of Minnesota
has halted blood-sugar screenings at a St. Paul high-rise residence
because monitoring equipment was being used on multiple patients,
thereby creating an infectious disease risk.
“The risk of HIV/AIDS, hepatitis B or hepatitis C infection from a
shared device is low, but there is still a risk,” the U said in a
statement released Thursday. “There have been no reported infections as a
result of this possible exposure.”
Blood-sugar screenings were being offered at Skyline, a high-rise
residence located in the Midway area of St. Paul that caters largely to
immigrant populations, university officials said.